0.6816
price down icon0.79%   -0.00545
after-market Handel nachbörslich: .64 -0.0416 -6.10%
loading
Schlusskurs vom Vortag:
$0.687
Offen:
$0.699
24-Stunden-Volumen:
21,045
Relative Volume:
0.86
Marktkapitalisierung:
$27.84M
Einnahmen:
$15.12M
Nettoeinkommen (Verlust:
$-52.48M
KGV:
-0.5274
EPS:
-1.2924
Netto-Cashflow:
$-36.52M
1W Leistung:
-0.29%
1M Leistung:
+6.16%
6M Leistung:
-11.96%
1J Leistung:
+4.21%
1-Tages-Spanne:
Value
$0.64
$0.699
1-Wochen-Bereich:
Value
$0.64
$0.7166
52-Wochen-Spanne:
Value
$0.512
$2.92

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile

Name
Firmenname
Barinthus Biotherapeutics Plc Adr
Name
Telefon
44 (0) 1865 818808
Name
Adresse
20400 CENTURY BLVD, GERMANTOWN
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2026-05-06
Name
Neueste SEC-Einreichungen
Name
BRNS's Discussions on Twitter

Compare BRNS vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
BRNS icon
BRNS
Barinthus Biotherapeutics Plc Adr
0.6816 28.06M 15.12M -52.48M -36.52M -1.2924
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.93 110.28B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
634.62 66.98B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
808.43 50.15B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.50 39.71B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
154.89 32.22B 742.00K -1.37B -1.07B -7.0731

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-05-25 Eingeleitet Jefferies Buy
2021-05-25 Eingeleitet Morgan Stanley Overweight
2021-05-25 Eingeleitet William Blair Outperform
2021-05-24 Eingeleitet H.C. Wainwright Buy

Barinthus Biotherapeutics Plc Adr Aktie (BRNS) Neueste Nachrichten

pulisher
May 21, 2026

Barinthus Biotherapeutics shareholders approve scheme of arrangement - Investing.com

May 21, 2026
pulisher
May 20, 2026

MARKER THERAPEUTICS (MRKR) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

May 20, 2026
pulisher
May 15, 2026

What Makes Biorestorative Therapies (BRTX) a New Buy Stock - Yahoo Finance

May 15, 2026
pulisher
May 12, 2026

Are KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders? - Morningstar

May 12, 2026
pulisher
May 01, 2026

Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Sahm

May 01, 2026
pulisher
Apr 30, 2026

Barinthus Biotherapeutics (NASDAQ: BRNS) cuts Q1 loss while pursuing Clywedog merger - Stock Titan

Apr 30, 2026
pulisher
Apr 13, 2026

What Makes Haleon PLC Sponsored ADR (HLN) a New Buy Stock - Yahoo Finance

Apr 13, 2026
pulisher
Mar 28, 2026

ProShares Russell 2000 Dividend Growers ETF $SMDV Shares Sold by Capital Investment Advisors LLC - Defense World

Mar 28, 2026
pulisher
Mar 20, 2026

All You Need to Know About Theravance Bio (TBPH) Rating Upgrade to Strong Buy - Yahoo Finance

Mar 20, 2026
pulisher
Mar 16, 2026

Are NSA, ULY, ESQ, BRNS Obtaining Fair Deals for their Shareholders? - Finviz

Mar 16, 2026
pulisher
Mar 14, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm

Mar 14, 2026
pulisher
Feb 26, 2026

Haleon PLC Sponsored ADR (HLN) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Feb 26, 2026
pulisher
Jan 15, 2026

Short Interest in Barinthus Biotherapeutics PLC Sponsored ADR (NASDAQ:BRNS) Grows By 72.8% - Defense World

Jan 15, 2026
pulisher
Jan 15, 2026

BioHarvest Sciences Inc. (NASDAQ:BHST) Sees Large Increase in Short Interest - Defense World

Jan 15, 2026
pulisher
Jan 03, 2026

Lowe’s Companies, Inc. $LOW Shares Acquired by Arbor Investment Advisors LLC - Defense World

Jan 03, 2026
pulisher
Dec 22, 2025

Barinthus Biotherapeutics PLC sponsored ADR (BRNS) upgraded to buy: What does it mean for the stock? - MSN

Dec 22, 2025
pulisher
Dec 15, 2025

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Dec 15, 2025
pulisher
Dec 15, 2025

Should I buy Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) - zacks.com

Dec 15, 2025
pulisher
Dec 10, 2025

Barinthus Bio reports positive initial data from celiac therapy trial - Investing.com India

Dec 10, 2025
pulisher
Nov 20, 2025

HC Wainwright Has Optimistic View of BRNS FY2025 Earnings - Defense World

Nov 20, 2025
pulisher
Nov 19, 2025

Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights - Finviz

Nov 19, 2025
pulisher
Nov 11, 2025

Barinthus Biotherapeutics Plc. ADR (BRNS) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews

Nov 11, 2025
pulisher
Oct 29, 2025

Linkers Industries Ltd (LNKS) Stock: Should Investors Follow These Insider Trades? - fostersleader.com

Oct 29, 2025
pulisher
Oct 02, 2025

Get in on Barinthus Biotherapeutics Plc. ADR’s (BRNS) buy-in window today! - setenews.com

Oct 02, 2025
pulisher
Sep 30, 2025

Barinthus Bio joins forces with metabolic disease biotech in reverse merger - Fierce Biotech

Sep 30, 2025
pulisher
Sep 11, 2025

Liminatus Pharma (LIMN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat

Sep 11, 2025
pulisher
Jun 22, 2025

Improved Revenues Required Before Barinthus Biotherapeutics plc (NASDAQ:BRNS) Stock's 29% Jump Looks Justified - Sahm

Jun 22, 2025
pulisher
Jan 31, 2025

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - Nasdaq

Jan 31, 2025
pulisher
Sep 03, 2024

Mexico Shingles Vaccine Market Size & Outlook, 2025-2030 - Grand View Research

Sep 03, 2024
pulisher
Aug 22, 2024

Asia Pacific Shingles Vaccine Market Size & Outlook, 2030 - Grand View Research

Aug 22, 2024
pulisher
Aug 21, 2024

North America Shingles Vaccine Market Size & Outlook, 2030 - Grand View Research

Aug 21, 2024
pulisher
Aug 03, 2024

What is the current Price Target and Forecast for Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) - Zacks Investment Research

Aug 03, 2024
pulisher
Jul 28, 2024

Middle East & Africa Shingles Vaccine Market Size & Outlook, 2030 - Grand View Research

Jul 28, 2024
pulisher
Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Investing.com UK

Jun 21, 2024
pulisher
May 11, 2024

Barinthus Biotherapeutics (BRNS) Stock Forecast and Price Target 2026 - MarketBeat

May 11, 2024
pulisher
May 10, 2024

Barinthus Biotherapeutics plc (BRNS) stock price, news, quote and history - Yahoo Finance UK

May 10, 2024
pulisher
Apr 08, 2024

Barinthus Biotherapeutics plc ADR Each Rep 1 Ord Share Spon share price - Hargreaves Lansdown

Apr 08, 2024
pulisher
Apr 06, 2024

Barinthus Biotherapeutics plc (BRNS) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 06, 2024
pulisher
Mar 28, 2024

Barinthus Biotherapeutics (BRNS) Stock Price, News & Analysis - MarketBeat

Mar 28, 2024
pulisher
Dec 20, 2023

symbol__ Stock Quote Price and Forecast - CNN

Dec 20, 2023
pulisher
Nov 22, 2023

BRNS - Finviz

Nov 22, 2023
pulisher
Nov 10, 2023

BRNS Stock Price and Chart — NASDAQ:BRNS - TradingView

Nov 10, 2023
pulisher
Nov 10, 2023

Barinthus Biotherapeutics (BRNS) Earnings Date and Reports 2026 - MarketBeat

Nov 10, 2023
pulisher
May 25, 2023

Biodexa Pharmaceuticals (BDRX) Short Interest & Short Float | Updated May 2026 - MarketBeat

May 25, 2023
pulisher
May 25, 2023

Bullfrog AI (BFRG) Short Interest & Short Float | Updated Apr 2026 - MarketBeat

May 25, 2023
pulisher
Jan 13, 2022

Mainz Biomed (MYNZ) Short Interest & Short Float | Updated Mar 2026 - MarketBeat

Jan 13, 2022
pulisher
Jan 28, 2021

Purple Biotech (PPBT) Short Interest & Short Float | Updated Mar 2026 - MarketBeat

Jan 28, 2021
pulisher
Jan 28, 2021

Enveric Biosciences (ENVB) Short Interest & Short Float | Updated Apr 2026 - MarketBeat

Jan 28, 2021
pulisher
Aug 12, 2020

Genprex (GNPX) Short Interest & Short Float | Updated Apr 2026 - MarketBeat

Aug 12, 2020
pulisher
Aug 10, 2020

Immuron (IMRN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat

Aug 10, 2020
pulisher
Aug 10, 2020

Amer Prem Water (HIPH) Short Interest & Short Float | Updated Mar 2026 - MarketBeat

Aug 10, 2020

Finanzdaten der Barinthus Biotherapeutics Plc Adr-Aktie (BRNS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
Kapitalisierung:     |  Volumen (24h):